Photodecontamination of blood components: Advantages and drawbacks

Clinical Hemorheology and Microcirculation

Volumn 18, Issue 4, 1998, Pages 299-308

  Santus, René ^a   Grellier, Philippe ^a   Schrével, Joseph ^a   Mazière, Jean Claude ^b   Stoltz, Jean Francois ^c  

^a MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

^c NANCY UNIVERSITÉ   (France)

Author keywords

Membranes; Parasites; Photodynamic reactions; Photosensitizers; Singlet oxygen; Virus

Indexed keywords

MEROCYANINE; METHYLENE BLUE; PHOTOSENSITIZING AGENT; PHTHALOCYANINE DERIVATIVE; PORPHYRIN DERIVATIVE; PSORALEN DERIVATIVE; VIRUS DNA; VIRUS PROTEIN;

ARTICLE; BLOOD STORAGE; INFECTION PREVENTION; PARASITE TRANSMISSION; PHOTODYNAMICS; PHOTOSENSITIZATION; VIRUS TRANSMISSION;

BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; HUMANS; PHOTOSENSITIZING AGENTS;

EID: 0031846985     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. J.L. Matthews, J.T. Newman, F. Sogandares-Bernal, M.M. Judy, H. Skiles, J.E. Leveson, A.J. Marengo-Rowe and T.C. Chanh, Photodynamic therapy of viral contaminants with potential for blood banking applications, Transfusion 28 (1988), 81-83.
2. J.E. Groopman et al., Antibody seronegative human T-lymphotropic virus type III (HTLV-III)-infected patients with acquired immunodeficiency syndrome-related disorders, Blood 66 (1985), 742-744.
3. S. Wendel and J.C.P. Dias, Transfusion transmitted Chagas' disease, in: Chagas' Disease (American Trypanosomiasis): Its Impact on Transfusion and Clinical Medicine, S. Wendel, Z. Brener and M.E. Carmargo, eds, ISBT Brazil '92, Sao Paulo, 1992, pp. 103-134.
4. E. Kohen, R. Santus and J.G. Hirschberg, Photobiology, Academic Press, New York, 1995.
5. K.G. Specht, W.R. Midden and M.R. Chedekel, Photocycloaddition of 4,5′,8-trimethylpsoralen and oleic acid methyl ester: product structures and reaction mechanism, J. Org. Chem. 54 (1989), 4125-4134.
6. C. Wallis and J.L. Melnick, Photodynamic inactivation of animal viruses: a review, Photochem. Photobiol. 4 (1965), 159-170.
7. B. Lambrecht, H. Mohr, J. Knüver-Hopf and H. Schmitt, Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light, Vox Sanguinis 60 (1991), 207-213.
8. H. Mohr, B. Bachmann, A. Klein-Struckmeier and B. Lambrecht, Virus inactivation of blood products by phenothiazine dyes and light, Photochem. Photobiol. 65 (1997), 441-445.
9. J. North, H. Neyndorff and J.G. Levy, Photosensitizers as virucidal agents, J. Photochem. Photobiol. B: Biol. 17 (1993), 99-108.
10. H. Mohr and B. Lambrecht, Optimization of parameters for photodynamic virus inactivation of human fresh plasma, Biotechnol. Blood Proteins 227 (1993), 255-260.
11. J.P. Reyftmann, P. Morlière, S. Goldstein, R. Santus, L. Dubertret and D. Lagrange, Interaction of human serum low density lipoproteins with porphyrins: a spectroscopic and photochemical study, Photochem. Photobiol. 40 (1984), 721-729.
12. H. Mohr, J. Knüver-Hopf, B. Lambrecht, H. Scheidecker and H. Schmitt. No evidence for neoantigens in human plasma after photochemical virus inactivation, Ann. Hematol. 65 (1992), 224-228.
13. D. Zucker-Franklin, S. Seremetis and Z.Y. Zheng, Internalization of human immunodeficiency virus type I and other retroviruses by megakaryocytes and platelets, Blood 75 (1990), 1920-1923.
14. B.L. Lin, H. Londe, J.M. Janda, C.V. Hanson and L. Corash, Photochemical inactivation of pathogenic bacteria in human platelet concentrates, Blood 83 (1994), 2698-2706.
15. R.Y. Dood, G. Moroff, S. Wagner, M.H. Dabay, E. Dorfman, V. George, A. Ribeiro, J. Shumaker and L.E. Benade, Inactivation of viruses in platelet suspensions that retain their in vitro characteristics: comparison of psoralen-ultraviolet A and merocyanine 540-visible light methods, Transfusion 31 (1991), 483-490.
16. L. Lin, G.P. Wiesehahn, P.A. Morel and L. Corash, Use of 8-methoxypsoralen and long wavelength ultraviolet radiation for decontamination of platelet concentrates, Blood 74 (1989), 517-525.
17. M.S. Platz, S.C. Park, C. Kasturi, S. Rai, J.N. Aebischer, T. Chen, L. Kulaga, R.P. Goodrich, S.O. Sowemimo-Coker, N.R. Yerram, B.H. Tay-Goodrich, P. Forster, S. Grandall and D. Jones, The design and development of selective viral inactivation sensitizers for sterilization of blood products, in: Prevention of Transfusion Mediated Diseases, F. Sieber, ed., CRC Press, Boca Raton, FL, 1995.
18. H. Margolis-Nuno, A. Bartley, E. Ben-Hur, T. Huima-Byron, H. MacGregor, R. Robinson, C.R. Valeri and B. Horowitz, Quencher mediated protection of platelet integrity during psoralen photoinactivation of viruses in platelet concentrates, Blood 82 (1993), 401a.
19. S.J. Wagner, R. White, L. Wolf and J. Chapman, Determination of residual 4′-aminomethyl-4,5′-trimethylpsoralen and mutagenicity testing following psoralen plus UVA treatment of platelet suspensions, Photochem. Photobiol. 57 (1993), 819-824.
20. C.R. Valeri, G. Ragno, H. MacGregor and L.E. Pivacek, The effect of disinfection on viability and function of baboon red blood cells, Photochem. Photobiol. 65 (1997), 446-450.
21. S. Rywkin, E. Ben-Hur, Z. Malik, A.M. Prince, S.Y. Li, M.E. Kenney, N.L. Oleinick and B. Horowitz. New phthalocyanines for photodynamic virus inactivation in red blood cell concentrates, Photochem. Photobiol. 60 (1994), 165-170.
22. E. Ben-Hur, H. Margolis-Nunno, P. Gottlied, S. Lustigman and B. Horowitz, Photodynamic decontamination of blood for transfusion, in: Photodynamic Therapy of Cancer II, SPIE, Vol. 2325, 1994, pp. 166-173.
23. J.M. O'Brien, D.K. Gaffney, T.P. Wang and F. Sieber, Merocyanine 540-sensitized photoinactivation of enveloped viruses in blood products: Site and mechanism of phototoxicity, Blood 80 (1992), 277-285.
24. S.J. Wagner, J.R. Stony, D.A. Mallory, R.R. Stromberg, L.E. Benade and L.I. Friedman, Red cell alterations associated with virucidal methylene blue phototreatment, Transfusion 33 (1993), 30-36.
25. S. Rywkin, L. Lenny, J. Goldstein, N.E. Geacintov, H. Margolis-Nunno and B. Horowitz, Importance of type I and type II mechanisms in the photodynamic inactivation of viruses in blood with aluminum phthalocyanine derivatives, Photochem. Photobiol. 56 (1992), 463-469.
26. R. Docampo, S.N.J. Moreno and F.S. Cruz, Enhancement of the cytotoxicity of crystal violet against Trypanosoma cruzi in the blood by ascorbate, Mol. Biochem. Parasitol. 27 (1988), 241-248.
27. D.M. Smith, D.L. Traul, L. McOlash and F. Sieber, Evaluation of merocyanine 540-sensitized photoirradiation as a method for purging malarially-infected red cells from blood, J. Infect. Dis. 163 (1991), 1312-1317.
28. P. Grellier, R. Santus, E. Mouray, V. Agmon, J.C. Mazière, D. Rigomier, A. Dagan, S. Gatt and J. Schrével, Photosensitized inactivation of Plasmodium falciparum and babesia divergens-infected erythrocytes in whole blood by lipophilic pheophorbide derivatives, Vox Sanguinis 72 (1997), 211-220.
29. P. Gottlieb, L.G. Shen, E. Chimezie, S. Bahng, M.E. Kenney, B. Horowitz and E. Ben-Hur, Inactivation of Trypanosoma cruzi trypomastigote forms in blood components by photodynamic treatment with phthalocyanines, Photochem. Photobiol. 62 (1995), 869-874.
30. P. Grellier, D. Rigomier, V. Clavey, J.C. Fruchart and J. Schrével, Lipid traffic between high density lipoproteins and Plasmodium falciparum in infected red blood cells, J. Cell Biol. 112 (1991), 267-277.